XML 86 R76.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Total revenues $ 85,729 $ 85,600 $ 172,937 $ 169,717
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 41,270 43,342 80,783 85,103
Product development (excluding stock compensation) 8,113 8,207 16,360 18,894
Sales and marketing (excluding stock compensation) 8,041 7,815 13,450 14,408
General and administrative expenses (excluding stock compensation) 18,076 18,878 37,540 38,274
Total expenses 82,102 87,749 161,150 172,454
Total Adjusted EBITDA 13,743 13,444 31,974 23,768
Operating Segments        
Segment Reporting Information [Line Items]        
Total expenses 71,986 72,156 140,963 145,949
Financial Health        
Segment Reporting Information [Line Items]        
Total revenues 54,284 54,509 110,417 107,948
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 29,308 30,269 56,499 59,866
Financial Health | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 54,284 54,509 110,417 107,948
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 28,842 30,162 55,915 59,685
Product development (excluding stock compensation) 3,002 1,904 6,111 4,331
Sales and marketing (excluding stock compensation) 5,029 5,012 8,859 9,295
General and administrative expenses (excluding stock compensation) 10,319 9,222 21,159 19,631
Total expenses 47,192 46,300 92,044 92,942
Total Adjusted EBITDA 7,092 8,209 18,373 15,006
Patient Care        
Segment Reporting Information [Line Items]        
Total revenues 31,445 31,091 62,520 61,769
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 11,962 13,073 24,284 25,237
Patient Care | Operating Segments        
Segment Reporting Information [Line Items]        
Total revenues 31,445 31,091 62,520 61,769
Cost of revenues (excluding amortization and depreciation and stock compensation expense) 11,790 12,950 24,031 25,152
Product development (excluding stock compensation) 4,868 6,048 9,798 14,097
Sales and marketing (excluding stock compensation) 2,784 2,592 4,179 4,763
General and administrative expenses (excluding stock compensation) 5,352 4,266 10,911 8,995
Total expenses 24,794 25,856 48,919 53,007
Total Adjusted EBITDA $ 6,651 $ 5,235 $ 13,601 $ 8,762